This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend CPC London

Legal Notice

CLINICAL PHARMACY CONGRESS IS SPONSORED BY THE PHARMACEUTICAL AND MED TECH INDUSTRIES VIA GRANTS, SPONSORSHIP, AND EXHIBITION PACKAGES. PHARMACEUTICAL COMPANIES HAVE SOLELY PROVIDED SPONSORSHIP THROUGH THE PURCHASE OF EXHIBITION SPACE AND/OR SPONSORED SPEAKER SESSIONS WITH NO FURTHER INPUT INTO THE ARRANGEMENTS OR AGENDA OF THE MEETING. SESSIONS DELIVERED WITH INPUT FROM OUR SPONSORS WILL ALWAYS BE MARKED ON THE PROGRAMME. A FULL LIST OF CONFIRMED SPONSORS FOR CLINICAL PHARMACY CONGRESS LONDON IS AVAILABLE HERE.  

Exhibitors

Subpage Hero

.

Dot Incorporation.

Stand: POD 4
  • | IT and Software
  • | Medical Devices, Equipment, and Supplies

About Dot Inc.

Dot Inc. is a global leader in accessible technology, creating innovative braille and tactile solutions that help people who are blind or visually impaired access information and manage daily life independently.

  • Founded in 2015
  • Multiple international awards for innovation and social impact
  • Used across healthcare, education, and public services.



Why this matters for UK pharmacies

Every patient has the right to understand their medication - independently and safely.  While packaging may include braille, personalised prescription instructions rarely do, creating a critical accessibility gap.


The award-winning Nemonic Dot Braille Printer, recognised at CES 2026 (Best Innovation Award) and with an iF Design Award, enables pharmacy teams to instantly produce clear braille labels for dosage and usage - no specialist knowledge required.


Accessible labelling is essential to safe medicines use. For patients with sight loss, braille provides direct, reliable access to instructions - supporting safer, more independent medication management aligned to the prescription.


Dot Inc. solutions help pharmacies to:

Improve patient safety
  • Reduce risk of medication errors caused by misidentifying similar packaging
  • Studies show braille labelling can reduce errors from 46% to 5%.

Support independence and adherence
  • Patients can identify medicines, confirm dosage, and follow instructions without assistance
  • Encourages correct use aligned to prescribed instructions.

Enable privacy and dignity
  • Removes the need to rely on others to read sensitive medical information.

Provide direct, accessible information
  • Immediate access to dosage, frequency, and safety instructions
  • Critical for patients managing multiple medications.

Support compliance and inclusive care
  • Helps meet legal accessibility duties
  • Builds patient confidence, trust, and control over their own care.



What We’re Showcasing


Nemonic Dot Braille Label Printer
(CES 2026 Best Innovation Award | iF Design Award)

  • Instantly produce clear braille labels for dosage and usage
  • Portable and easy to use for non-braille readers
  • No specialist training required
  • Integrates into existing pharmacy workflows
  • Supports safe, independent medication management.



Visit us at POD 4

  • Live demonstrations
  • Practical pharmacy use cases
  • Learn how to improve patient safety, independence, and confidence for blind and partially sighted patients. 

Attend our Presentation
Showcase Theatre | Friday 8th May (Day 1): 10am – 10:15am

Contact

Justin Gould
Chief Commercial Director, EMEA
Dot Inc.
E: justin@dotincorp.com 

Address

Gasandigital 2-67, 20F, 2002, Geumcheon-gu, Seoul, Korea
Seoul
Seoul
2-67, 20F
Korea, Republic of
Visit website
Contact Exhibitor

Contact Exhibitor


Products

Loading
View all Exhibitors

Newsletter Sign Up